ORBIMED ADVISORS LLC – Arcutis Biotherapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$53.50M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-10.32%
quarter
Arcutis Biotherapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -41.44% | -1.98M shares | -48.38M | $19.11 | 2.8M |
Q2 2022 | share | Decrease | -21.27% | -1.29M shares | -15.08M | $21.31 | 4.78M |
Q1 2022 | share | 0.00% | 0 shares | -8.99M | $19.26 | 6.07M | |
Q4 2021 | share | 0.00% | 0 shares | -19.13M | $20.48 | 6.07M | |
Q3 2021 | share | 0.00% | 0 shares | -20.65M | $23.89 | 6.07M | |
Q2 2021 | share | 0.00% | 0 shares | -9.96M | $27.29 | 6.07M | |
Q1 2021 | share | 0.00% | 0 shares | 4.85M | $28.93 | 6.07M | |
Q4 2020 | share | Increase | +29.95% | 1.4M shares | 33.91M | $28.13 | 6.07M |
Q3 2020 | share | 0.00% | 0 shares | -4.39M | $29.3 | 4.67M | |
Q2 2020 | share | 0.00% | 0 shares | 2.05M | $30.24 | 4.67M | |
Q1 2020 | share | Increase | 0.00% | 4.67M shares | 139.28M | $29.8 | 4.67M |